Alicia Probst

发表

Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low‐grade glioma

N. André, D. Frappaz, J. Grill, 2021, British journal of clinical pharmacology.

Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis

N. André, D. Frappaz, J. Grill, 2022, Cancer Chemotherapy and Pharmacology.

Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial.

G. Ferron, F. Lécuru, E. Leblanc, 2020, Gynecologic oncology.

In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R.

B. Maillère, F. Castelli, N. Szely, 2009, Molecular immunology.

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study

I. Fournier, F. Guyon, C. Pomel, 2023, Cancers.

Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial

K. McHugh, J. Merks, G. Calareso, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant therapeutic monoclonal antibodies: mechanisms of action in relation to structural and functional duality.

G. Thibault, H. Watier, N. Congy‐Jolivet, 2007, Critical reviews in oncology/hematology.

Human CD4 T cell epitopes selective for Vaccinia versus Variola virus

B. Maillère, F. Castelli, Aurore Besse, 2012, Molecular immunology.

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)

G. Bouche, N. Néant, C. Solas, 2023, Cancers.

Randomized phase 2 trial of the combination of vincristine and irinotecan with or without temozolomide, in children and adults with refractory or relapsed rhabdomyosarcoma (RMS).

K. McHugh, G. Calareso, J. Chisholm, 2019, Journal of Clinical Oncology.

METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.

I. Aerts, M. Deley, Alicia Probst, 2024, European journal of cancer.

The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial

S. Motton, C. Jauffret, H. El Hajj, 2024, Annals of surgical oncology.